Deadly E. coli Strain Decoded

Article

The secret to the deadly 2011 E. coli outbreak in Germany has been decoded, thanks to research conducted at Michigan State University.

The deadliest E. coli outbreak ever, which caused 54 deaths and sickened more than 3,800 people, was traced to a particularly virulent strain that researchers had never seen in an outbreak before. In the current issue of the academic journal PLoS ONE, a team of researchers led by Shannon Manning, MSU molecular biologist and epidemiologist, suggests a way to potentially tame the killer bacteria.

The strain, E. coli O104:H4, shares some characteristics as other deadly E. coli bacteria, but its combination is novel. Researchers havent determined the mechanism it uses to cause disease, although Manning and her team were able to find the strains Achilles heel ­ its biofilm.

By focusing on the bacterias biofilm, the grouping of many E. coli bacteria that stick to a cells surface and grow encased in a self-produced protective coat, Manning and colleagues were able to determine why it was so deadly. When the bacterium found in Germany forms a biofilm, it begins to make more toxic genes like the Shiga toxin.

Increased production of the Shiga toxin is the probable culprit that contributed to so many incidents of kidney damage and death during the 2011 outbreak, Manning says.

What made the German outbreak so different is that many victims suffering from kidney failure were adults, she says. Rather than attacking adults, other types of E. coli that produce Shiga toxins typically damage kidneys of children under 10.

In addition, the incubation period was considerably longer among individuals infected with the German outbreak strain compared to individuals infected with E. coli O157, a similar bacterium that can also cause illness and death. Manning believes this is because the German strain needs a longer period of time to form a biofilm, whereas biofilms are not important for O157 infections.

Our research demonstrates that biofilm formation is critical for toxin production and kidney damage, she says. If we can block the bacteria from forming a stable biofilm, then it is likely that we can prevent future E. coli O104:H4 infections.

The next phase of Mannings research is already focusing on creating mutant strains in an effort to prevent the bacterium from forming a biofilm. This would prevent the disease completely since the conditions would not be favorable for bacterial growth.

Chris Waters, MSU assistant professor of microbiology and molecular genetics, and scientists from the University of Michigan and the Michigan Department of Community Health contributed to the research.

Mannings research was funded in part by the National Institutes of Health (U19AI090872), the U.S. Department of Agriculture and MSU AgBioResearch.

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content